Shield Therapeutics plc

Research Shield Therapeutics plc (1JS) on Bullrun: market cap EUR 72.73M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker1JS
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 72.73M
• Financial periodFY2025
• RevenueEUR 49.70M
• Revenue growth54.4%
• Net income-EUR 17.66M
• Free cash flow-EUR 3.68M
• Gross margin46.4%

Valuation Snapshot

latest market cap is EUR 72.73M.

About Shield Therapeutics plc

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.

Frequently asked questions

What is Shield Therapeutics plc's market cap?

Shield Therapeutics plc's market capitalization is EUR 72.73M.

What does Shield Therapeutics plc do?

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.